Click here for slides on this topic


Blood pressure (BP)

Pressure exerted by circulating blood upon the walls of blood vessels.
The following content matched the glossary term: Blood pressure (BP)

AHA ADA prevention of CVD in T2D - Glycemic Targets

Top

Summary of glycemic target recommendations, including A1C goals, from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension

Top

Tikkanen I, Narko K, Zeller C, et al; for the EMPA-REG BP Investigators. Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension. Diabetes Care. 2014;Epub ahead of print. DOI: 10.2337/dc14-1096.

ADVANCE-ON: Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

Top

Zoungas S, Chalmers J, Neal B, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014;[epub ahead of print]. doi: 10.1056/NEJMoa1407963.

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

T195-04

Top

Patient education handout exploring the connection between diabetes and cardiovascular disease.

ADA 2016 Children & Adolescents

Top

Recommendations for treating and managing diabetes in children from the 2016 ADA guidelines

ADA 2016 Cardiovascular Disease (CVD) and Diabetes

Top

Recommendations for CVD management, including lipids and BP, in patients with type 2 diabetes from the 2016 ADA diabetes guidelines

Clinical Insights in Diabetes Newsletter October 2013

Top

Clinical Insights® in Diabetes newsletter October 2013

Exploring DPP-4 CV safety in SAVOR-TIMI 53 and EXAMINE, CV outcomes in Look AHEAD, relationship between gastric bypass and A1C and cardiometabolic risk factors, metabolic effects of bariatric surgery and medical therapy in STAMPEDE, statin use and diabetes risk, severe hypoglycemia and CVD disease risk.

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia

Top

Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. JAMA. 2013;309(21):2240-2249.

1 2 3 4 5 6 7 8 9 10  ... Next 

Slide Library Results

Search Results for: Blood pressure (BP) Slides Found: 25
Diet Does Not Affect BP in Patients With Type 2 Diabetes in the Short-Term
High-Carbohydrate Diet Elevates BP in Patients With Type 2 Diabetes
RENAAL: Risk Reduction With Losartan--Design
Impact of Higher Heart Rate on Development of Cardiometabolic Risk Factors After 20 Years
ADVANCE Substudy: Effects of BP Lowering and Intensive Glucose Control on Retinopathy
ACCORD BP: Effects of Intensive BP-Control on Type 2 Diabetes
ACCORD BP: Effects of Intensive BP-Control on Type 2 Diabetes
BP and Type 2 Diabetes Risk in African Americans and Whites: Design
BP and Type 2 Diabetes Risk in African Americans and Whites: Results
ARIC: Role of A1C in Predicting Hypertension—Design
ARIC: Role of A1C in Predicting Hypertension—Results
CANTATA-D2: Significant Reductions in Systolic BP with Canagliflozin Vs Sitagliptin at 52 Weeks
CANTATA-M: Significant Reductions in Systolic BP Seen with Canagliflozin vs Placebo at 26 Weeks
ESH/ESC Hypertension Guidelines: Classification of BP Levels
ESH/ESC Hypertension Guidelines: Hypertension Treatment Options
ESH/ESC Hypertension Guidelines: Hypertension Treatment for People With Metabolic Syndrome
BP Rates and All-Cause Mortality in Newly Diagnosed Type 2 Diabetes: Design
BP Rates and All-Cause Mortality in Newly Diagnosed Type 2 Diabetes: Results
IDF 2012 Type 2 Diabetes Guidelines Blood Pressure Targets | NDEI
IDF 2012 Type 2 Diabetes Guidelines Blood Pressure Treatment | NDEI
Reduction in SBP Lowers Cardiovascular Risk in Type 2 Diabetes PPT | NDEI
SBP Reduction Microvascular Outcomes in Type 2 Diabetes PPT | NDEI
BP-Lowering Treatment & Macrovascular Outcomes Type 2 Diabetes | NDEI
AACE 2015 Guidelines Hypertension Management PPT | NDEI
ACCORD BP Post-hoc Analysis: Design